Skip to content

Feed Screener Search MCP Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search MCP Methodology

Pricing Sign in

FREDERIC LOMBARD — INNATE PHARMA insider · InsiderLens

Home / Insiders / FREDERIC LOMBARD

FREDERIC LOMBARD

CHIEF FINANCIAL OFFICER at INNATE PHARMA · on record since Jan 17, 2025

Insider trading activity of FREDERIC LOMBARD

No transactions on record for FREDERIC LOMBARD.

Companies where FREDERIC LOMBARD has traded

INNATE PHARMA2 tx · Jan 15, 2026

Track record of FREDERIC LOMBARD

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of FREDERIC LOMBARD

Co-insiders of FREDERIC LOMBARD

Claire de Lingua de Saint BlanquatINNATE PHARMA
DFC LANGLOIS Société CivileINNATE PHARMA
Eric VivierINNATE PHARMA
Henry WheelerINNATE PHARMA
HERVE BRAILLYINNATE PHARMA
mondher mahjoubiINNATE PHARMA
Nicola BeltraminelliINNATE PHARMA
ODILE BELZUNCEINNATE PHARMA
Odile LAURENTINNATE PHARMA
YANNIS MORELINNATE PHARMA

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
INNATE PHARMA	Jan 15, 2026	Buy	50,000	1.61 EUR	—	AMF
INNATE PHARMA	Jan 17, 2025	Buy	24,000	0.00 EUR	—	AMF